Search

CRISPR, ViaCyte Team Up to Develop Stem Cell-Based Diabetes Therapy

CRISPR, VIACYTE TEAM UP TO DEVELOP STEM CELL-BASED DIABETES THERAPY

ViaCyte's attempts to develop a stem cell therapy for diabetes have been stymied by the immune system, which recognizes the implanted...

RESEARCH SCIENTIST I | BPS BIOSCIENCE INC

Description/Key Responsibilities: BPS Bioscience Inc. is a leading provider of recombinant proteins, assay kits, and stable cell lines...

 
 
 
Xconomy's San Francisco Event to Showcase Biotech's Next Generation

XCONOMY'S SAN FRANCISCO EVENT TO SHOWCASE BIOTECH'S NEXT GENERATION

The life sciences and biomedicine are a constant field of tension between cutting-edge ideas and breakthroughs, and time-tested procedures...

 
 
 
Hope for a cancer vaccine as scientists cure skin melanoma in 100% of mice in a trial

HOPE FOR A CANCER VACCINE AS SCIENTISTS CURE SKIN MELANOMA IN 100% OF MICE IN A TRIAL

Researchers at the Scripps Research Institute and the University of Texas injected mice with an immunotherapy drug and a chemical called...

After a High-Speed Decade, Agios CEO David Schenkein to Step Aside

AFTER A HIGH-SPEED DECADE, AGIOS CEO DAVID SCHENKEIN TO STEP ASIDE

David Schenkein, the longtime CEO of Agios Pharmaceuticals, will step aside next year after transforming what was once a high-risk...

 
 
 
Y-mAbs Plans IPO to Advance Two Pediatric Cancer Drugs to the FDA

Y-MABS PLANS IPO TO ADVANCE TWO PEDIATRIC CANCER DRUGS TO THE FDA

Neuroblastoma, a rare pediatric cancer, has no FDA-approved treatments for patients who relapse after the first line of therapies....

Bio Roundup: EpiPen Shortage, Bluebird's Bet, Biotech IPOs & More

BIO ROUNDUP: EPIPEN SHORTAGE, BLUEBIRD'S BET, BIOTECH IPOS & MORE

It's back-to-school season and that means it's time to load up on school supplies. For many students and schools, one crucial item...

 
 
 
Simple Blood Test Can Predict Immunotherapy Efficacy in Bladder Cancer Patients

SIMPLE BLOOD TEST CAN PREDICT IMMUNOTHERAPY EFFICACY IN BLADDER CANCER PATIENTS

Simple blood test can help identify bladder cancer patients who may not benefit from immunotherapy.

Subject CAR-Ts to price competition or randomized trials to ensure even coverage, expert says

SUBJECT CAR-TS TO PRICE COMPETITION OR RANDOMIZED TRIALS TO ENSURE EVEN COVERAGE, EXPERT SAYS

CMS could run trials of CAR-Ts in lymphoma if unsure of their similarity on benefit to patients and ancillary service costs, Dr. Peter...

 
 
 
Veterinary Highlights: Immunotherapy for Canine Osteosarcoma Preliminary Study Results

VETERINARY HIGHLIGHTS: IMMUNOTHERAPY FOR CANINE OSTEOSARCOMA PRELIMINARY STUDY RESULTS

"Vaccine and T-cell infusion combination approach yields “impressive survival times and minimal side effects” I have written about...

 
 
 
 
 
 
Bio Roundup: Big Bucks For Calico, Data Dumps & The IPO Wave Rolls On

BIO ROUNDUP: BIG BUCKS FOR CALICO, DATA DUMPS & THE IPO WAVE ROLLS ON

If you're running a privately held biotech, the time to go public is now. Clinical data already in hand or not, biotechs have charged...

Lethal Prostate Cancer Treatment may Benefit from Combination Immunotherapy: Study

LETHAL PROSTATE CANCER TREATMENT MAY BENEFIT FROM COMBINATION IMMUNOTHERAPY: STUDY

A genetic subset of prostate cancer may benefit from the use of combination checkpoint immunotherapy.

 
 
 
Skyhawk Lands $100M from Funding & Celgene Pact for RNA-Targeted Drugs

SKYHAWK LANDS $100M FROM FUNDING & CELGENE PACT FOR RNA-TARGETED DRUGS

Almost exactly a year ago, a Boston-area cancer immunotherapy startup led by Bill Haney announced its first partnership , with Celgene....

Immune Profile for Successful Cancer Immunotherapy Identified

IMMUNE PROFILE FOR SUCCESSFUL CANCER IMMUNOTHERAPY IDENTIFIED

Multiple immune cell types must be present in tumors for 'checkpoint inhibitor' therapies to be effective.

 
 
 
Predicting the Success of Immunotherapy in Cancer Patients

PREDICTING THE SUCCESS OF IMMUNOTHERAPY IN CANCER PATIENTS

New study discovers a method for predicting the likelihood of treatment success in cancers.